The results of a hemolysis assay are interpreted by comparing the hemoglobin release from nanoparticle-treated samples to the controls. Generally, a hemolysis percentage below 5% is considered acceptable for biomedical applications. Results are often presented as a graph showing the percentage of hemolysis versus nanoparticle concentration. A low hemolysis percentage indicates good biocompatibility, while a high percentage suggests potential toxicity.
